Goldman Sachs Cuts Versigent Price Target to $58.00 From $59.00
Goldman Sachs has lowered its price target for Versigent to $58.00 per share from $59.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.